Use of a polypeptide with an angiotensin-converting enzyme 2 (ACE2) activity for treating tumours (with the exception of lung cancer)

摘要

Use of a recombinant soluble form of human angiotensin-converting enzyme 2 (ACE2) for the production of a medicament for the treatment of tumour diseases, with the exception of lung cancer.